Oncology

Diet quality could play a role in the progression of prostate cancer for men undergoing active surveillance.

The U.S. FDA has approved a wearable device for treating metastatic non-small cell lung cancer in adults. Used with PD-1/PD-L1 inhibitors or docetaxel, it showed a median survival of 13.2 months.

A new study from The University of Texas MD Anderson Cancer Center has revealed that a combination of dual immunotherapy and chemotherapy improves outcomes for patients with metastatic NSCLC who harbor specific mutations.

Breast cancer deaths have declined by 44% since 1989, but rising diagnoses and racial disparities highlight the need for targeted care and early detection.

Greater BRCA genetic testing among men has been highlighted as a critical need in a recently published review

One-third of popular social media articles about breast, colorectal, lung, and prostate cancer contained misleading or harmful information, according to a new study.

Inherited BRCA mutations may sharply increase the risk of early-onset multiple myeloma, according to new research.

Protective cells can be converted into tumor promoters after the immune system has been hijacked by cancer.